Suppr超能文献

重新思考不同程度脏层胸膜侵犯的非小细胞肺癌病理T分类的选择:一项基于监测、流行病学和最终结果(SEER)数据库的研究

Rethinking the Selection of Pathological T-Classification for Non-Small-Cell Lung Cancer in Varying Degrees of Visceral Pleural Invasion: A SEER-Based Study.

作者信息

Fang Pu, Cheng Jiayi, Lu Youjin, Fu Lin

机构信息

Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Anhui Medical University, Hefei, China.

Department of Toxicology, Anhui Medical University, Hefei, China.

出版信息

Front Surg. 2022 May 19;9:902710. doi: 10.3389/fsurg.2022.902710. eCollection 2022.

Abstract

BACKGROUND

The T classification of non-small-cell lung cancer (NSCLC) was upgraded from T1 to T2 when accompanied by visceral pleural invasion (VPI). However, the association between VPI and prognostic outcomes was obscure in NSCLC patients with ≤3 cm tumor size (TS), which leaded the controversy of selection of T classification. The goal was to evaluate the effect of VPI on the prognosis of NSCLC with ≤ 3cm TS and present a modified T classification.

METHODS

A total of 14,934 NSCLC patients without distant metastasis were recruited through a retrospective study in the SEER database. The effect of VPI on lung cancer specific survival (LCSS) was evaluated using survival curve and COX regression analysis in NSCLC patients with ≤3 cm TS.

RESULTS

Although there was no difference of the LCSS of PL0 and PL1 patients with ≤2 cm TS in patients without lymph node (LN) metastasis, the LCSS was lower in PL2 patients than those in PL0 (T1a:  < 0.001; T1b:  = 0.001). Moreover, the LCSS was decreased in PL1 and PL2 patients with 2-3 cm TS compared with PL0 (T1c: PL1, < 0.001; PL2,  = 0.009) of patients without LN metastasis. No difference of LCSS was observed in patients with LN metastasis between PL0 with PL1 and PL2.

CONCLUSION

In NSCLC patients without LN metastasis and TS ≤ 2 cm, tumor with PL1 should remain defined as T1, tumor with PL2 should be defined as T2. However, 2-3 cm TS patients with PL1 or PL2 should both defined as T2. Meanwhile, ≤3 cm TS patients with LN metastasis can be regarded as T1, whether NSCLC patients accompanied with PL1 or PL2.

摘要

背景

非小细胞肺癌(NSCLC)伴有脏层胸膜侵犯(VPI)时,T分类从T1升级为T2。然而,在肿瘤大小(TS)≤3 cm的NSCLC患者中,VPI与预后结果之间的关联尚不明确,这导致了T分类选择的争议。目的是评估VPI对TS≤3 cm的NSCLC患者预后的影响,并提出一种改良的T分类。

方法

通过对SEER数据库的回顾性研究,共纳入14934例无远处转移的NSCLC患者。采用生存曲线和COX回归分析评估VPI对TS≤3 cm的NSCLC患者肺癌特异性生存(LCSS)的影响。

结果

在无淋巴结(LN)转移的患者中,TS≤2 cm的PL0和PL1患者的LCSS无差异,但PL2患者的LCSS低于PL0患者(T1a:<0.001;T1b:=0.001)。此外,在无LN转移的患者中,2-3 cm TS的PL1和PL2患者的LCSS与PL0患者相比降低(T1c:PL1,<0.001;PL2,=0.009)。在有LN转移的患者中,PL0与PL1和PL2之间的LCSS无差异。

结论

在无LN转移且TS≤2 cm的NSCLC患者中,伴有PL1的肿瘤应仍定义为T1,伴有PL2的肿瘤应定义为T2。然而,2-3 cm TS伴有PL1或PL2的患者均应定义为T2。同时,有LN转移的≤3 cm TS患者,无论是否伴有PL1或PL2,均可视为T1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e0/9406813/8a653752dceb/fsurg-09-902710-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验